GIST presenting as refractory iron-deficiency anaemia in paediatric patient
- 9 March 2022
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 15 (3) , e248365
Abstract
Gastrointestinal stromal tumours (GISTs) are very rare gastrointestinal (GI) mesenchymal tumours affecting only 0.02 children/million/year below the age of 14 years. We reported a 9-year-old girl presented to emergency department with pallor and haemoglobin of 50 g/L. Extensive workup for anaemia suggested iron-deficiency anaemia secondary to GI loss. Ultimately after blood transfusion of packed cells, she was discharged with a haemoglobin of 92 g/L with iron supplementation. Upper endoscopy showed incidental antral nodularity with biopsy proven helicobacter gastritis and an isolate 3–4 cm suspicious mass in the lesser curvature. Abdomen imaging confirmed the gastric mass in addition to two lesions, one retroperitoneal and one paraspinal. She undergone open laparotomy with complete surgical resection of the gastric and retroperitoneal masses with histological confirmation of GIST and paraganglioma. This case emphasises the importance of proper examination of the stomach at endoscopy and to illustrate that although anaemia is common in paediatric age group it may be reflect serious medical condition even in normal looking child.Keywords
This publication has 19 references indexed in Scilit:
- Pediatric gastrointestinal stromal tumor: Report of two novel patients harboring germline variants in SDHB and SDHC genesCancer Genetics, 2020
- Pediatric/“Wildtype” gastrointestinal stromal tumorsSeminars in Pediatric Surgery, 2016
- Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studiesCancer Epidemiology, 2016
- Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) – A reviewThe International Journal of Biochemistry & Cell Biology, 2014
- Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trialThe Lancet, 2013
- Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinibPediatric Blood & Cancer, 2009
- A systematic review on the clinical diagnosis of gastrointestinal stromal tumorsJournal of Surgical Oncology, 2008
- Pediatric KIT–Wild-Type and Platelet-Derived Growth Factor Receptor α–Wild-Type Gastrointestinal Stromal Tumors Share KIT Activation but not Mechanisms of Genetic Progression with Adult Gastrointestinal Stromal TumorsCancer Research, 2007
- PDGFRA Activating Mutations in Gastrointestinal Stromal TumorsScience, 2003
- Familial paraganglioma and gastric stromal sarcoma: A new syndrome distinct from the Carney triadAmerican Journal of Medical Genetics, 2002